EverHint – EMA 10 + Price + MACD – Top 4 Signals for Sep 09, 2026

Excerpt: 4 signals. Technology leads (3). price range $24-$405.

What This Signal Is

Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.

Entry Criteria:

• Buy: Price > EMA10 AND MACD line crosses above signal line
• Sell: Price < EMA10 AND MACD line crosses below signal line
• Minimum ADV: $40M (liquidity filter)
• Earnings buffer: 7 days pre/post earnings
• Fresh signal: All conditions met on today's close

Holding period: 1-3 weeks | Risk level: Medium-High

Market Context

Equity markets are experiencing a mild but broad-based pullback, with all three major indices posting losses on the session. The Nasdaq's slightly steeper decline relative to the Dow suggests some near-term pressure on growth-oriented names, which is relevant context for momentum-based strategies like EMA/MACD crossover signals. When the short-term trend weakens even modestly, price-to-moving-average relationships can become noisier, and traders should be prepared for signals that may take longer to confirm or that carry slightly higher false-positive risk.

The VIX reading of 16.46, up nearly 5% on the day, is worth monitoring closely. While this level remains within a historically moderate range, the sharp single-session spike indicates that options markets are pricing in greater near-term uncertainty. For intraday strategies, elevated and rising volatility typically widens price swings around key technical levels, which can accelerate signal triggers but also increase the likelihood of whipsaw behavior around EMA crossovers.

Despite the broader market softness, Technology remains the top sector generating signals today, suggesting relative strength or at least active momentum setups within that space even as the Nasdaq dips. This divergence between sector signal activity and index-level weakness may reflect rotational positioning rather than broad risk-off sentiment. Traders following EMA and MACD-based entries in Technology should weigh the current volatility uptick against these momentum cues, favoring tighter risk management and confirming entries with volume where possible.

🟢 Buy Signals (4 of 4 total)

Ranked by RSI (lower RSI = more oversold for buy signals)

Field Notes

Sector concentration: Technology (3), Healthcare (1)

Data coverage: 0.0% insider (7d), 0.0% congressional (30d), 0.0% earnings, 75.0% news (7d)

Peer Analysis

TNGX (Tango Therapeutics, Inc.): Leads 5 peers: SEPN ($37.97), URGN ($45.00), PROK ($1.85), EYPT ($4.34), BCAX ($23.64)

FFIV (F5, Inc.): Leads 5 peers: KSPI ($100.00), GEN ($29.76), RBRK ($88.82), OKTA ($172.80), DT ($50.60)

BAND (Bandwidth Inc.): Leads 5 peers: OSPN ($16.10), DAVA ($2.81), CRNC ($8.28), CCSI ($36.38), PRTH ($5.42)

AKAM (Akamai Technologies, Inc.): Leads 5 peers: DOX ($59.81), PAYC ($215.58), IDCC ($339.34), PEGA ($35.03), SAIL ($17.58)

Recent Headlines

AKAM (Akamai Technologies, Inc.)

• Akamai Technologies, Inc. (AKAM) Presents at Citi's 2026 Global TMT Conference Transcript
• Head-To-Head Survey: WM Technology (NASDAQ:MAPS) & Akamai Technologies (NASDAQ:AKAM)

BAND (Bandwidth Inc.)

• Bandwidth Promotes Emily Harlan to General Counsel and Secretary

TNGX (Tango Therapeutics, Inc.)

• Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vlad's Take

Today's signals: Strong sector concentration in Technology (3 signals) suggests sector-specific rotation.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📢 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.